References
Shand DG (1984) Alpha 1-acid glycoprotein and plasma lidocaine binding. Clin Pharmacokinet 9:27–31
Wojcicki J, Kozlowsky K, Drozdzik M, Wojcicki M (2002) Lidocaine elimination in patients with liver cirrhosis. Acta Pol Pharm 59(4):321–324
Testa R, Campo N, Caglieris S, Risso D, Alvarez S, Arzani L et al (1998) Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis. Hepatogastroenterology 45(19):154–159
McKindley DS, Boulet J, Sachdeva K, Wang P, Chichester C (2002) Endotoxic shock alters the pharmacokinetics of lidocaine and monoethylglycinexylidide. Shock 17(3):199–204
Collinsworth KA, Strong JM, Atkinson AJ Jr, Winkle RA, Perlroth F, Harrison DC (1975) Pharmacokinetics and metabolism of lidocaine in patients with renal failure. Clin Pharmacol Ther 18(1):59–64
Lili C, Shibata N, Yoshikawa Y, Takada K (2003) Effect of glycerol-induced acute renal failure on the pharmacokinetics of lidocaine after transdermal application in rats. Biol Pharm Bull 26(8):1150–1154
du Souich P, Saunier C, Hartemann D, Allam M (1992) Effect of acute and chronic moderate hypoxia on the kinetics of lidocaine and its metabolites and on regional blood flow. Pulm Pharmacol Ther 5(1):9–16
Pardridge WM, Sakiyama R, Fierer G (1984) Blood-brain barrier transport and brain sequestration of propranolol and lidocaine. Am J Physiol 247(3):R582–588
Laurikainen E, Marttila R, Lindberg R, Kanto J (1983) Penetration of lidocaine and its active desethylated metabolite into cerebrospinal fluid in man. Eur J Clin Pharmacol 25(5):639–641
Tsai PS, Buerkle H, Huang LT, Lee TC, Yang LC, Lee JH (1998) Lidocaine concentrations in plasma and cerebrospinal fluid after systemic bolus administration in humans. Anesth Analg 87(3):601–604
Parfitt K (ed) (1999) Martindale, the complete drug reference, 32nd edn. Pharmaceutical Press, London
Elad S, Cohen G, Zylber-Katz E, Findler M, Galili D, Garfunkel AA et al (1999) Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients. J Oral Pathol Med 28(4):170–172
Wu FL, Razzaghi A, Souney PF (1993) Seizure after lidocaine for bronchoscopy: case report and review of the use of lidocaine in airway anaesthesia. Pharmacotherapy 13(1):72–78
Denaro CP, Benowitz NL (1989) Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide. Med Toxicol Adverse Exp 4(6):412–428
Zdziarsky P (2001) Hoigne syndrome as an acute non-allergic reaction to different drugs: case reports. Pol Merkuriusz Lek 10(60):453–455
Ameer B, Burlingame MB, Harman EM (1989) Systemic absorption of lidocaine in elderly and young adults undergoing bronchoscopy. Pharmacotherapy 9(2):74–81
Smith M, Wolfram W, Rose R (1992) Toxicity—seizures in an infant caused by (or related to) oral viscous lidocaine use. J Emerg Med 10(5):587–590
Mofenson HC, Caraccio TR, Miller H, Greensher J (1983) Lidocaine toxicity from topical mucosal application. With a review of the clinical pharmacology of Lidocaine. Clin Pediatr 22(3):190–192
Mehra P, Caiazzo A, Maloney P (1998) Lidocaine toxicity. Anesth Prog 45(1):38–41
Sharma SC, Rama PR, Miller GL, Coccio EB, Coulter LJ (1996) Systemic absorption and toxicity from topically administered lidocaine during transesophageal echocardiography. J Am Soc Echocardiogr 9(5):710–711
Rincon E, Baker RL, Iglesias AJ, Duarte AM (2000) CNS toxicity after topical application of EMLA cream on a toddler with molluscum contagiosum. Pediatr Emerg Care 16(4):252–254
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brosh-Nissimov, T., Ingbir, M., Weintal, I. et al. Central nervous system toxicity following topical skin application of lidocaine. Eur J Clin Pharmacol 60, 683–684 (2004). https://doi.org/10.1007/s00228-004-0814-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-004-0814-4